Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts
- PMID: 16364709
- DOI: 10.1016/j.bone.2005.11.005
Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts
Abstract
Bone mass is maintained by a fine balance between bone formation by osteoblasts and bone resorption by osteoclasts. Although osteoblasts and osteoclasts have different developmental origins, it is generally believed that the differentiation, function, and survival of osteoclasts are regulated by osteogenic cells. We have previously shown that the extracellular matrix protein, biglycan (Bgn), plays an important role in the differentiation of osteoblast precursors. In this paper, we showed that Bgn is involved in regulating osteoclast differentiation through its effect on osteoblasts and their precursors using both in vivo and in vitro experiments. The in vivo osteolysis experiment showed that LPS (lipopolisaccharide)-induced osteolysis occurred more rapidly and extensively in bgn deficient mice compared to wild type (WT) mice. To further understand the mechanism of action, we determined the effects of Bgn on 1alpha, 25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3))-induced osteoclast differentiation and bone resorption in an co-culture of calvariae-derived pre-osteoblasts and osteoclast precursors derived from spleen or bone marrow. Time course and dose response experiments showed that tartrate-resistant acid phosphatase-positive multinuclear cells appeared earlier and more extensively in the co-cultures containing calvarial cells from bgn deficient mice than WT mice, regardless of the genotype of osteoclast precursors. The osteoblast abnormality that stimulated osteoclast formation appeared to be independent of the differential production of soluble RANKL and OPG and, instead, due to a decrease in osteoblast maturation accompanied by increase in osteoblastic proliferation. In addition to the imbalance between differentiation and proliferation, there was a differential decrease in secretory leukocyte protease inhibitor (slpi) in bgn deficient osteoblasts treated with 1,25-(OH)(2)D(3). These findings point to a novel molecular factor made by osteoblasts that could potentially be involved in LPS-induced osteolysis.
Similar articles
-
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.FASEB J. 2004 Jun;18(9):948-58. doi: 10.1096/fj.03-0899com. FASEB J. 2004. PMID: 15173106
-
Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.J Bone Miner Res. 2002 Jan;17(1):91-100. doi: 10.1359/jbmr.2002.17.1.91. J Bone Miner Res. 2002. PMID: 11771673
-
Biglycan deficiency interferes with ovariectomy-induced bone loss.J Bone Miner Res. 2003 Dec;18(12):2152-8. doi: 10.1359/jbmr.2003.18.12.2152. J Bone Miner Res. 2003. PMID: 14672350
-
Cellular and molecular effects of growth hormone and estrogen on human bone cells.APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review.
-
Osteoblast-osteoclast interactions.Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21. Connect Tissue Res. 2018. PMID: 28324674 Free PMC article. Review.
Cited by
-
Diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma.Oncotarget. 2020 Aug 4;11(31):2982-2994. doi: 10.18632/oncotarget.27674. eCollection 2020 Aug 4. Oncotarget. 2020. PMID: 32821344 Free PMC article.
-
Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.Hum Mol Genet. 2010 Dec 15;19(24):4790-8. doi: 10.1093/hmg/ddq409. Epub 2010 Sep 24. Hum Mol Genet. 2010. PMID: 20871099 Free PMC article.
-
Rewiring cells: synthetic biology as a tool to interrogate the organizational principles of living systems.Annu Rev Biophys. 2010;39:515-37. doi: 10.1146/annurev.biophys.050708.133652. Annu Rev Biophys. 2010. PMID: 20192780 Free PMC article. Review.
-
Biglycan regulates bone development and regeneration.Front Physiol. 2023 Feb 16;14:1119368. doi: 10.3389/fphys.2023.1119368. eCollection 2023. Front Physiol. 2023. PMID: 36875017 Free PMC article.
-
Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.J Biol Chem. 2010 Oct 29;285(44):34126-33. doi: 10.1074/jbc.M110.125328. Epub 2010 Aug 21. J Biol Chem. 2010. PMID: 20729550 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous